Ophthalmoplegia refers to weakness or paralysis of one or more of the extra-ocular muscles, resulting in restrictive eye movements. Some of the major causes include myasthenia gravis, brainstem stroke, and thyroid eye disease. Symptomatic treatments include artificial tears, lid taping or patching, and protective eyeglasses. Ophthalmoplegia can lead to double vision, which can impact physical functioning and quality of life. The global market for ophthalmoplegia treatments is driven by rising neurological disorders, growing awareness about eye care, and new drug therapies.
The Global Ophthalmoplegia Market is estimated to be valued at US$ 510 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global Ophthalmoplegia market are Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG.
The market provides growth opportunities through expansion into developing markets and development of new formulations for better treatment efficacy and compliance. Technological advancements include drug delivery technologies like sustained release formulations and nanotechnology based drug delivery for neurological disorders treatment.
Market Drivers
Rising prevalence of neurological disorders like myasthenia gravis and thyroid eye diseases is a key growth driver for the ophthalmoplegia market. According to WHO, over 1 billion people worldwide suffer from neurological disorders. Increased research activities by key players to develop novel therapies for refractive eye conditions will also contribute to market growth. Growing geriatric population prone to age-related eye conditions further drives the demand for ophthalmoplegia treatment products.
Current Challenges In The Global Ophthalmoplegia Market
The global ophthalmoplegia market is growing at a steady pace. However, there are certain challenges restraining the market growth. One of the major challenges is lack of awareness about eye disorders and available treatment options among people, especially in developing regions. This leads to delay in diagnosis and treatment. Secondly, the high cost of surgeries and medications for eye disorders is a major concern. Eye care treatments being expensive, many people in low and middle-income countries cannot afford them. This further impacts the market demand. Additionally, lack of comprehensive healthcare insurance cover for eye ailments poses affordability challenges.
SWOT Analysis
Strength: Growing geriatric population prone to eye diseases and awareness drives by eye care foundations have boosted demand. Advanced diagnostic techniques aid accurate diagnosis and staging.
Weakness: Expensive surgical procedures and medications limit affordability in poorer regions. Limited healthcare budgets in developing nations are a bottleneck.
Opportunity: Untapped low and middle-income markets with large patient pools present lucrative opportunities. Novel drug delivery approaches can make therapies more affordable and accessible.
Threats: Threat from alternative treatment options like physiotherapy. Risk of side effects associated with drugs hamper compliance and market growth prospects.
Geographical Regions
North America currently dominates the global ophthalmoplegia market in terms of value. This is attributed to availability of advanced healthcare infrastructure and rising per capita healthcare spending. Europe follows North America owing to growing awareness about eye care and favorable reimbursement scenario. Asia Pacific is emerging as a fast-growing regional market fueled by expanding healthcare sectors in India and China along with growing population and disposable incomes. Latin America and Middle East & Africa also offer promising growth prospects for key players over the forecast period.
Fastest Growing Regions
Asia Pacific region is envisaged to witness fastest growth in the global ophthalmoplegia market during the forecast period. Developing economies in the region are witnessing significant economic development along with rising healthcare expenditures. This will boost access to ophthalmoplegia diagnostic services and treatments. Moreover, the geriatric population prone to ocular disorders is also expanding steadily in Asia Pacific, offering potential opportunities to market players.
What Are The Key Data Covered In This Global Ophthalmoplegia Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Ophthalmoplegia Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Ophthalmoplegia Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Ophthalmoplegia Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Ophthalmoplegia Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Ophthalmoplegia Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Ophthalmoplegia Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Ophthalmoplegia Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.